Dr. Mehran Movassaghi

Dr. Mehran Movassaghi
Mehran Movassaghi, M.D., is a board-certified, fellowship trained urologist treating patients in Santa Monica California. He has vast experience with endourology and men’s health. He provides a variety of treatments for conditions including prostate enlargement and cancer, low testosterone, erectile dysfunction, testicular cancer, kidney stones, and infertility including vasectomies. Before joining St. John’s Physician Partners, Dr. Movassaghi began the first of its kind comprehensive men’s health program in the Los Angeles area. Dr. Movassaghi earned his medical degree at the University of California, Los Angeles, Geffen School of Medicine. He then served his internship at Stanford University Hospital & Clinics and his residencies at Stanford University Hospital & Clinic and USC (University of Southern California). He later completed a prestigious fellowship at Cedars Sinai Medical Center. Dr. Movassaghi is a member of the American Urological Association, the Endourological Society and sits on the board of the American Society for Men’s Health. Throughout his tenure, he has published numerous peer-reviewed articles in the areas of endourology, quality of life and integrative medicine. He is the founder of the Los Angeles Prostate Cancer 5K and an avid advocate of prevention for both urologic and other forms of chronic illness. Dr. Movassaghi believes our body is the most complex piece of machinery ever made, and each system is dependent on the other for optimal performance. At every milestone in life, men face different health challenges. Screening, education, and early treatment are the most effective means for longevity and optimal quality of life. He looks forward to welcoming new patients and accepts most major forms of insurance.

Languages Spoken:

English, Farsi, Spanish

Medical School:

UCLA

Residency:

Stanford

Fellowship:

Cedars Sinai

Undergraduate:

UCLA

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only